IgG4-negative autoimmune pancreatitis with sclerosing cholangitis and colitis: Possible association with primary sclerosing cholangitis?

Internal Medicine

Volumn 47, Issue 10, 2008, Pages 943-948

  Saeki, Keita ^a   Hozawa, Shigenari ^a   Miyata, Naoteru ^a   Nishizawa, Toshihiro ^a   Soma, Hiromitsu ^a   Iwao, Yasushi ^a   Kameyama, Kaori ^a   Hibi, Toshifumi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoimmune pancreatitis; Cholangitis; Colitis; Primary sclerosing cholangitis

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN G4; PREDNISOLONE; IMMUNOGLOBULIN G; STEROID;

ADULT; ARTICLE; AUTOIMMUNE PANCREATITIS; BILE DUCT OBSTRUCTION; CASE REPORT; CHOLANGIOGRAPHY; CLINICAL FEATURE; COLITIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FIBERSCOPE ENDOSCOPY; HISTOPATHOLOGY; HUMAN; MALE; PRIMARY SCLEROSING CHOLANGITIS; SCLEROSING CHOLANGITIS; AUTOIMMUNE DISEASE; BLOOD; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PANCREATITIS; PATHOLOGY;

ADMINISTRATION, ORAL; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS, SCLEROSING; COLITIS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PANCREATITIS; STEROIDS;

EID: 45849097181     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0613     Document Type: Article

References (15)

1. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 38: 982-984, 2003.
2. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344: 732-738, 2001.
3. Uehara T, Hamano H, Kawa S, Sano K, Honda T, Ota H. Distinct clinicopathological entity 'autoimmune pancreatitis associated sclerosing cholangitis'. Pathol Int 55: 405-411, 2005.
4. Nakazawa T, Ohara H, Sano H, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc 60: 937-944, 2004.
5. Horiuchi A, Kawa S, Hamano H, Hayama M, Ota H, Kiyosawa K. ERCP features in 27 patients with autoimmune pancreatitis. Gastrointest Endosc 55: 494-499, 2002.
6. Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Morphological changes after steroid therapy in autoimmune pancreatitis. Scand J Gastroenterol 39: 1154-1158, 2004.
7. Ito T, Nakano I, Koyanagi S, et al. Autoimmune pancreatitis as a new clinical entity: three cases of autoimmune pancreatitis with effective steroid therapy. Dig Dis Sci 42: 1458-1468, 1997.
8. Kamisawa T, Okamoto A, Funata N. Clinicopathological features of autoimmune pancreatitis in relation to elevation of serum IgG4. Pancreas 31: 29-31, 2005.
9. Kamisawa T, Egawa N, Nakajima H, et al. Gastrointestinal findings in patients with autoimmune pancreatitis. Endoscopy 37 (11): 1127-1130, 2005.
10. Nishino T, Oyama H, Hashimoto E, et al. Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol 42: 550-559, 2007.
11. Takikawa H, Takamori Y, Tanaka A, et al. Analysis of 388 cases of primary sclerosing cholangitis in Japan Presence of a subgroup without pancreatic involvement in older patients. Hepatol 29: 153-159, 2004.
12. Nakazawa T, Ohara H, Sano H, et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas 30: 20-25, 2005.
13. Nishino T, Toki F, Oyama H, Shimizu K, Shiratori K. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med 45: 497-501, 2006.
14. Kawa S, Hamano H, Umemura T, Kiyosawa K, Uehara T. Sclerosing cholangitis associated with autoimmune pancreatitis. Hepatol Res 37: S487-S495, 2007.
15. Sewkani A, Kapoor S, Sharma S, Naik S, Debbarma MK, Varshney S. IgG4 negative sclerosing cholangitis associated with autoimmune pancreatitis. JOP 6 (3): 269-273, 2005.